MicroRNA Profiling in Chronic Limb-Threatening Ischemia Their Role in Arteriogenesis
- PMID: 40365156
- PMCID: PMC12068916
- DOI: 10.1055/a-2504-1911
MicroRNA Profiling in Chronic Limb-Threatening Ischemia Their Role in Arteriogenesis
Abstract
Chronic limb-threatening ischemia (CLTI) represents poses a substantial threat with escalating mortality and amputation rates. Despite the existence of various clinical techniques for diagnosing CLTI, the role of microRNAs (miRNAs) in arteriogenesis remains ambiguous. Comprehensive knowledge on miRNAs may facilitate the advancement of targeted therapy pertaining to the enhancement of collateral blood flow in obstructed vessels. Therefore, this study aimed at analyzing arteriogenesis-associated plasma miRNA profiles in patients with CLTI using gene expression. Samples were acquired from the collateral arteries (CA group, n = 3) and the contralateral healthy limb (healthy artery; HA group, n = 3) of a single set of patients with CLTI. The RNA extracted from the samples was assessed for concentration and purity. A normalization factor was used to address variations in analyte abundance and/or quality across the samples. Subsequently, individual RNA molecules were directly quantified and subjected to comparative analysis between the CA and HA groups to identify the miRNAs involved in arteriogenesis. The five arteriogenesis-related miRNAs exhibiting maximum upregulation were miR-301b-3p, miR-221-5p, miR-639, miR-34a-5p, and let-7a-5p, while the five most downregulated miRNAs included miR-151a-5p, miR-371a-5p, miR-651-5p, miR-510-5p, and miR-660-5p. Summarily, this study documented marked upregulation and downregulation of miRNAs associated with arteriogenesis in the collateral arteries of patients with CLTI as compared with their contralateral healthy limbs. Possible mechanisms involved, including the regulation of YAP/TAZ pathway, TGFBR3 mRNA, SIRT1 expression, and other processes have shown to be modulated by miRNAs fluctuations.
Keywords: SIRT1 expression; TGFBR3 mRNA; YAP/TAZ pathway; arteriogenesis; chronic limb-threatening ischemia; microRNA; sequencing.
International College of Angiology. This article is published by Thieme.
Conflict of interest statement
Conflict of Interest None declared.
Similar articles
-
MicroRNAs in oral fluids (saliva and gingival crevicular fluid) as biomarkers in orthodontics: systematic review and integrated bioinformatic analysis.Prog Orthod. 2021 Oct 11;22(1):31. doi: 10.1186/s40510-021-00377-1. Prog Orthod. 2021. PMID: 34632546 Free PMC article.
-
Exploring the Mechanism of Acupuncture in Improving Ovarian Function in Rats with Poor Ovarian Response Using High-Throughput Sequencing.Comb Chem High Throughput Screen. 2025;28(8):1443-1457. doi: 10.2174/0113862073365843241223093834. Comb Chem High Throughput Screen. 2025. PMID: 39838669
-
Infusion techniques for peripheral arterial thrombolysis.Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD000985. doi: 10.1002/14651858.CD000985.pub3. Cochrane Database Syst Rev. 2021. PMID: 34786692 Free PMC article.
-
A comprehensive investigation of identifying miRNA biomarkers and their potential role in age-related cataract by meta-analysis and bioinformatics analysis.Graefes Arch Clin Exp Ophthalmol. 2025 May;263(5):1307-1325. doi: 10.1007/s00417-024-06723-3. Epub 2025 Jan 6. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 39760860
-
The role of mir-151a-5p in tumorigenesis; A systematic review.Pathol Res Pract. 2023 Sep;249:154576. doi: 10.1016/j.prp.2023.154576. Epub 2023 Jun 1. Pathol Res Pract. 2023. PMID: 37562284
References
-
- Diehm C, Lange S, Darius H et al.Association of low ankle brachial index with high mortality in primary care. Eur Heart J. 2006;27(14):1743–1749. - PubMed
-
- ESC Scientific Document Group . Aboyans V, Ricco J-B, Bartelink M EL et al.ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS) Eur Heart J. 2018;39(09):763–816. - PubMed
-
- Berger J S, Hochman J, Lobach I, Adelman M A, Riles T S, Rockman C B. Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories. J Vasc Surg. 2013;58(03):673–810. - PubMed
-
- Varu V N, Hogg M E, Kibbe M R. Critical limb ischemia. J Vasc Surg. 2010;51(01):230–241. - PubMed
-
- TASC II Working Group Norgren L, Hiatt W R, Dormandy J A, Nehler M R, Harris K A, Fowkes F G.Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 200745(1, suppl S):S5–S67. - PubMed
LinkOut - more resources
Full Text Sources